Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 12, 2006, Pages 1884-1893

  Kovacs Nolan, Jennifer ^a   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antibody response; B and T cell epitope; Human rotavirus; Neutralization epitope; Peptide antigen; VP8

Indexed keywords

ANTIGEN; CARRIER PROTEIN; EPITOPE; GLUTAMINYLTYROSYLISOLEUCYLLYSYLALANYLASPARAGINYLSERYL LYSYLPHENYLALANYLISOLEUCYLGLYCYLISOLEUCYLTHREONYLGLUTAMYLLEUCINE; HYBRID PROTEIN; METHIONYLALANYLSERYLLEUCYLISOLEUCYLTYROSYLARGINYLGLUTAMINYLLEUCYLLEUCINE; NEUTRALIZING ANTIBODY; PEPTIDE ANTIBODY; PROTEIN SUBUNIT; ROTAVIRUS VACCINE; TETANUS TOXIN; THIOREDOXIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; HUMAN ROTAVIRUS; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID VECTOR; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RNA-BINDING PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN ROTAVIRUS A;

EID: 33750610963     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.07.015     Document Type: Article

References (51)

1. Miller M.A., and McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type B-, Streptococcus pneumoniae-conjugate, and rotavirus vaccines in national immunization schedules. Health Econ. 9 (2000) 19-35
2. Widdowson M.-A., Bresee J.S., Gentsch J.R., and Glass R.I. Rotavirus disease and its prevention. Curr. Opin. Gastroenterol. 21 (2004) 26-31
3. Higo-Moriguchi K., Akahori Y., Iba Y., Kurosawa Y., and Taniguchi K. Isolation of monoclonal antibodies that neutralize human rotavirus. J. Virol. 78 (2004) 3325-3332
4. Reilly R.M., Domingo R., and Sandhu J. Oral delivery of antibodies-Future pharmacokinetic trends. Clin. Pharmacokinet. 4 (1997) 313-323
5. Kapikian A.Z., Hoshino Y., and Chanock R.M. In: Knipe D.M., and Howley P.M. (Eds). Field's Virology. 4th Ed. (2001), Lippincott Williams and Wilkins, Philadelphia 1787-1833
6. Prasad B.V.V., Wang G.J., Clerx J.P.M., and Chiu W. Three-dimensional structure of rotavirus. J. Mol. Biol. 199 (1988) 269-275
7. Ludert J.E., Krishnaney A.A., Burns J.W., Vo P.T., and Greenberg H.B. Cleavage of rotavirus VP4 in vivo. J. Gen. Virol. 77 (1996) 391-395
8. Lee J., Babiuk L.A., Harland R., Gibbons E., Elazhary Y., and Yoo D. Immunological response to recombinant VP8* subunit protein of bovine rotavirus in pregnant cattle. J. Gen. Virol. 76 (1995) 2477-2483
9. Yoo D., Lee J., Harland R., Gibbons E., Elazhary Y., and Babiuk L.A. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*. Adv. Exp. Med. Biol. 412 (1997) 405-411
10. Kang D.K., Kim P.H., Ko E.J., Seo J.Y., Seong S.Y., Kim Y.H., Kwon I.C., Jeong S.Y., and Yang J.M. Peroral immunization of microencapsulated human VP8 in combination with cholera toxin induces intestinal antibody responses. Mol. Cells 9 (1999) 609-616
11. Gil M.T., de Souza C.O., Asensi M., and Buesa J. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Viral Immunol. 13 (2000) 187-200
12. Kovacs-Nolan J., Mine Y., and Yoo D. Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem. J. 376 (2003) 269-275
13. Boeckler C., Dautel D., Schelte P., Frisch B., Wachsmann D., Klein J.P., and Schuber F. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes. Eur. J. Immunol. 29 (1999) 2297-2308
14. Francis M.J. Synthetic peptides. In: Robinson A., Farrar G., and Wiblin C. (Eds). Methods in Molecular Medicine: Vaccine Protocols (1996), Humana Press Inc., Totowaf 75-90
15. Haro I., and Gomara M.J. Different approaches to potentiate the immune response induced by a 12-mer synthetic peptide. Curr. Protein Pept. Sci. 1 (2000) 125-137
16. Haro I., and Gomara M.J. Design of synthetic peptide constructs for the vaccine development against viral infections. Curr. Protein Pept. Sci. 5 (2004) 425-433
17. Zegers N.D., and Boersma W.J.M. Use of T cell epitopes in raising immune responses. In: Zegers N.D., Boersma W.J.A., and Claassen E. (Eds). Immunological Recognition of Peptides in Medicine and Biology (1995), CRC Press, Inc., New York 105-123
18. Diethelm-Okita B.M., Okita D.K., Banaszak L., and Conti-Fine B.M. Universal epitopes for human CD4 cells on tetanus and diphtheria toxins. J. Infect. Dis. 181 (2000) 1001-1009
19. Ho P.C., Mutch D.A., Winkel K.D., Saul A.J., Jones G.L., Doran T.J., and Rzepczyk C.M. Identification of two promiscuous T cell epitopes from tetanus toxin. Eur. J. Immunol. 20 (1990) 477-483
20. Kaumaya P.T.P., Kobs-Conrad S., Seo Y.H., Lee H., VanBuiskirk A.M., Feng N., Sheridan J.F., and Stevens V. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J. Mol. Recognit. 6 (1993) 81-94
21. 19. Infect. Immun. 68 (2000) 2102-2109
22. Falugi F., Petracca R., Mariani M., Luzzi E., Mancianti S., Carinci V., Melli M.L., Finco O., Wack A., Di Tommaso A., De Magistris M.T., Costantino P., Del Giudice G., Abrignani S., Rappuoli R., and Grandi G. Rationally designed strings of promiscuous CD4+ T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines. Eur. J. Immunol. 31 (2001) 3816-3824
23. Franke E.D., Corradin G., and Hoffman S.L. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. J. Immunol. 159 (1997) 3424-3433
24. Jemmerson R. Effects of conformation, amino acid sequence, and carrier coupling on the immunological recognition of peptide and protein antigens. In: Zegers N.D., Boersma W.J.A., and Claassen E. (Eds). Immunological Recognition of Peptides in Medicine and Biology (1995), CRC Press, Inc., New York 213-225
25. Cohen S.N., Chang A.C.Y., and Hsu L. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. U. S. A. 69 (1972) 2110-2114
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227 (1970) 680-695
27. Kovacs-Nolan J., Sasaki E., Yoo D., and Mine Y. Cloning and expression of human rotavirus spike protein, VP8*, in Escherichia coli. Biochem. Biophys. Res. Commun. 282 (2001) 1183-1188
28. Frank R., and Owerwin H. SPOT synthesis. In: Morris G.E. (Ed). Methods in Molecular Biology vol. 66 (1996), Humana Press Inc, New Jersey 149-169
29. Coulson B.S., and Masendycz P.J. Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay. J. Clin. Microbiol. 28 (1990) 1652-1654
30. Francis M.J., Hastings G.Z., Clarke B.E., Brown A.L., Beddel A.L., Rowlands D.J., and Brown F. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology 69 (1990) 171-176
31. Partidos C., Stanley C., and Steward M. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur. J. Immunol. 22 (1992) 2675-2680
32. Borras-Cuesta F., Petit-Camurdan A., and Fedon Y. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells. Eur. J. Immunol. 17 (1987) 1213-1215
33. Pillai S., Dermody K., and Metcalf B. Immunogenicity of genetically engineered glutathione S-transferase fusion proteins containing a T-cell epitope from diphtheria toxin. Infect. Immun. 63 (1995) 1535-1540
34. Fryauff D.J., Mouzin E., Church L.W., Ratiwayanto S., Hadiputranto H., Sutamihardja M.A., Widjaja H., Corradin G., Subianto B., and Hoffman S.L. Lymphocyte response to tetanus toxin T-cell epitopes: effects of tetanus vaccination and concurrent malaria prophylaxis. Vaccine 17 (1999) 59-63
35. Kumar A., Arora R., Kaur P., Chauhan V.S., and Sharma P. Universal T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J. Immunol. 148 (1992) 1499-1505
36. Vasconcelos N.-M., Siddique A.B., Ahlborg N., and Berzins K. Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes. Vaccine 23 (2004) 343-352
37. Kato H., Takeuchi H., Oishi Y., Senpuku H., Shimura N., Hanada N., and Nisizawa T. The immunogenicity of various peptide antigens inducing cross-reacting antibodies to a cell surface protein antigen of Streptococcus mutans. Oral Microbiol. Immunol. 14 (1999) 213-219
38. Fernández M., Snijders A., Benaissa-Trouw B.J., Harmsen M., Snippe H., and Kraaijeveld C.A. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. J. Virol. 67 (1993) 5843-5848
39. Maillère B., and Hervé M. The specificity of antibodies raised against a T-cell peptide is influenced by peptide amidation. Mol. Immunol. 14 (1997) 1003-1009
40. Partidos C., Stanley C., and Steward M. The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences. Mol. Immunol. 29 (1992) 651-658
41. Peterson E.M., Cheng X., Zhenhai Q., and De La Maza L.M. The effect of orientation within a chimeric peptide on the immunogenicity of Chlamydia trachomatis epitopes. Mol. Immunol. 33 (1996) 335-339
42. Azevedo M.S.P., Yuan L., Pouly S., Gonzales A.M., Jeong K.I., Nguyen T.V., and Saif L.J. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J. Virol. 80 (2006) 372-382
43. Broekhuijsen M.P., Van Rijn J.M.M., Blom A.J.M., Pouwels P.H., Enger-Valk B.E., Brown F., and Francis M.J. Fusion proteins with multiple copies of the major antigenic determinant and foot-and-mouth disease virus protect both the natural host and laboratory animals. J. Gen. Virol. 68 (1987) 3137-3143
44. Enea V., Arnot D., Schmidt E.C., Cochrane A., Gwadz R., and Nussenzweig R.S. Circumsporozoite gene of Plasmodium cynomolgi (Gombak): cDNA cloning and expression of the repetitive circumsporoziote epitope. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 7520-7524
45. Schuman J.T., Grinstead J.S., Apostolopoulos V., and Campbell P.A. Structural and dynamic consequences of increasing repeats in a MUCI peptide tumor antigen. Biopolymers 77 (2005) 107-120
46. Van Regenmortel M.H.V., and Muller S. Synthetic peptides as antigens. In: van der Vliet P.C. (Ed). Laboratory Techniques in Biochemistry and Molecular Biology Vol. 28 (1999), Elsevier, New York
47. Liu W., Peng Z., Liu Z., Lu Y., Ding J., and Chen Y.-H. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 23 (2004) 366-371
48. Liu W., and Chen Y.-H. High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins. Eur. J. Immunol. 35 (2005) 505-514
49. Partidos C.D., Obeid O.E., and Steward M.W. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Immunology 77 (1992) 262-266
50. Steward M.W., Partidos C.D., D'Mello F., and Howard C.R. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 11 (1993) 1405-1414
51. Shaw D.M., Stanley C.M., Partidos C.D., and Steward M.W. Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. Mol. Immunol. 30 (1993) 961-968